Ross C. McKiernan

1.6k citations
10 papers · 1.3k indexed · h-index 10
Topics
MicroRNA in disease regulation (6 papers)Circular RNAs in diseases (3 papers)RNA Interference and Gene Delivery (3 papers)

In The Last Decade

Ross C. McKiernan

10 papers receiving 1.3k citations

Peers

Ross C. McKiernan
Comparison fields: 5 of 91
  • Molecular Biology 768
  • Cancer Research 624
  • Cellular and Molecular Neuroscience 217
  • Genetics 208
  • Biomaterials 183
Replace Raffaella Mariotti with:
Raffaella Mariotti Italy
Teng Ma China
Filip Šimunović Germany
Tamara Roitbak United States
Nisim Perets Israel
Zhengliang Gao China
Marina Boido Italy
Xuyi Chen China
Kazuyoshi Nakanishi Japan
Ross C. McKiernan relative to Raffaella Mariotti Italy Raffaella Mariotti's profile →
Citations per field
00.5×7.4×
Raffaella Mariotti · 1×
Citations per year

Countries citing papers authored by Ross C. McKiernan

Since Specialization
Citations

This map shows the geographic impact of Ross C. McKiernan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross C. McKiernan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross C. McKiernan more than expected).

Fields of papers citing papers by Ross C. McKiernan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross C. McKiernan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross C. McKiernan. The network helps show where Ross C. McKiernan may publish in the future.

Co-authorship network of co-authors of Ross C. McKiernan

This figure shows the co-authorship network connecting the top 25 collaborators of Ross C. McKiernan. A scholar is included among the top collaborators of Ross C. McKiernan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross C. McKiernan. Ross C. McKiernan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 15
2 90
3 124
4 44
5 24
6 105
7 72
8 383
9 164
10 276

About Ross C. McKiernan

Ross C. McKiernan is a scholar working on Cancer Research, Developmental Neuroscience and Molecular Biology, having authored 10 papers that have together received 1.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Cancer Research (624 citations), Developmental Neuroscience (75 citations) and Biomaterials (183 citations). Ross C. McKiernan has collaborated with scholars based in Ireland, United States and Spain. Frequent co-authors include David C. Henshall, Eva M. Jiménez‐Mateos, Raymond L. Stallings, Tobías Engel, Takanori Sano, Matthew G. Haugh, Ciara M. Murphy, Cornelia Altenbuchner, Fergal J. O’Brien and Isabella Bray. Their work appears in journals such as Nature Medicine, PLoS ONE and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026